Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.2.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-10155.5China
BA.2.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BM.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.15ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.19ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.6.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.48ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.31ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.25ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GA.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.37ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAY.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.60ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
FH.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CJ.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HZ.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.69ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.98ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.71ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HT.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.90ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.06China
FB.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.18.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.26ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.32ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.26.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.06China
FK.1.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FK.1.2.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FK.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.18ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LP.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.3.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
KP.3.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LF.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.2.3.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LQ.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LY.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used